Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SRSD101
- Development stage
- Phase 1
- Lead developer
- Sirius Therapeutics
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Small Molecules
- Administration
- Subcutaneous
01
Overview
SRSD101 is an investigational small interfering RNA (siRNA) therapeutic developed by Sirius Therapeutics for the treatment of dyslipidemia, specifically targeting primary hypercholesterolemia. The drug works by selectively inhibiting the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA, thereby reducing PCSK9 protein levels. PCSK9 is a key regulator of low-density lipoprotein cholesterol (LDL-C) metabolism; its inhibition leads to increased clearance of LDL-C from the bloodstream, offering a novel approach to lowering cholesterol levels in patients at risk for cardiovascular disease. SRSD101 is currently being evaluated in Phase 1 clinical trials in China[1][2][4][7][9].
02
Targets
PCSK9 (Proprotein convertase subtilisin/kexin type 9)
Beyond the preview
Go deeper on SRSD101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SRSD101.